Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Emergence of a Novel Recombinant Norovirus GII.P16-GII.12 Strain Causing Gastroenteritis, Alberta, Canada.

Pabbaraju K, Wong AA, Tipples GA, Pang XL.

Emerg Infect Dis. 2019 Aug;25(8):1556-1559. doi: 10.3201/eid2508.190059.

2.

Simultaneous Detection and Differentiation between Wild-Type and Vaccine Measles Viruses by a Multiplex Real-Time Reverse Transcription-PCR Assay.

Pabbaraju K, Gill K, Wong AA, Tipples GA, Hiebert J, Severini A, Fonseca K, Tellier R.

J Clin Microbiol. 2019 Mar 28;57(4). pii: e01828-18. doi: 10.1128/JCM.01828-18. Print 2019 Apr.

3.

Genetic characterization of measles virus genotype D6 subacute sclerosing panencephalitis case, Alberta, Canada.

Pabbaraju K, Fonseca K, Wong S, Koch MW, Joseph JT, Tipples GA, Tellier R.

J Neurovirol. 2018 Dec;24(6):720-729. doi: 10.1007/s13365-018-0668-7. Epub 2018 Oct 5.

PMID:
30291564
4.

Simultaneous detection of Zika, Chikungunya and Dengue viruses by a multiplex real-time RT-PCR assay.

Pabbaraju K, Wong S, Gill K, Fonseca K, Tipples GA, Tellier R.

J Clin Virol. 2016 Oct;83:66-71. doi: 10.1016/j.jcv.2016.09.001. Epub 2016 Sep 1.

PMID:
27614319
5.

Determining rubella immunity in pregnant Alberta women 2009-2012.

Lai FY, Dover DC, Lee B, Fonseca K, Solomon N, Plitt SS, Jaipaul J, Tipples GA, Charlton CL.

Vaccine. 2015 Jan 29;33(5):635-41. doi: 10.1016/j.vaccine.2014.12.022. Epub 2014 Dec 19.

PMID:
25533327
6.

Full-genome analysis of avian influenza A(H5N1) virus from a human, North America, 2013.

Pabbaraju K, Tellier R, Wong S, Li Y, Bastien N, Tang JW, Drews SJ, Jang Y, Davis CT, Fonseca K, Tipples GA.

Emerg Infect Dis. 2014 May;20(5):887-91. doi: 10.3201/eid2005.140164.

7.

Bioinformatics of varicella-zoster virus: single nucleotide polymorphisms define clades and attenuated vaccine genotypes.

Chow VT, Tipples GA, Grose C.

Infect Genet Evol. 2013 Aug;18:351-6. doi: 10.1016/j.meegid.2012.11.008. Epub 2012 Nov 24.

8.

Mumps epidemic in orthodox religious low-vaccination communities in the Netherlands and Canada, 2007 to 2009.

Wielders CC, van Binnendijk RS, Snijders BE, Tipples GA, Cremer J, Fanoy E, Dolman S, Ruijs Wl, Boot HJ, de Melker HE, Hahne SJ.

Euro Surveill. 2011 Oct 13;16(41). pii: 19989.

9.

Rubella diagnostic issues in Canada.

Tipples GA.

J Infect Dis. 2011 Sep 1;204 Suppl 2:S659-63. doi: 10.1093/infdis/jir430.

PMID:
21954263
10.

Detection of mumps virus RNA by real-time one-step reverse transcriptase PCR using the LightCycler platform.

Leblanc JJ, Pettipas J, Davidson RJ, Tipples GA, Hiebert J, Hatchette TF.

J Clin Microbiol. 2008 Dec;46(12):4049-51. doi: 10.1128/JCM.01446-08. Epub 2008 Oct 22.

11.

Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature.

Hatchette T, Tipples GA, Peters G, Alsuwaidi A, Zhou J, Mailman TL.

Pediatr Infect Dis J. 2008 Jan;27(1):75-7. Review.

PMID:
18162946
12.

Application of DNA array technology for diagnostic microbiology.

Booth SA, Drebot MA, Tipples GA, Ng LK.

Can J Infect Dis. 2000 Nov;11(6):291-4. No abstract available.

13.

A prospective assessment of cytomegalovirus immune evasion gene transcription profiles in transplant patients with cytomegalovirus infection.

Humar A, Kumar D, Gray M, Moussa G, Venkataraman S, Kumar R, Tipples GA.

Transplantation. 2007 May 15;83(9):1200-6.

PMID:
17496536
14.

Evaluation of commercial rubella immunoglobulin G avidity assays.

Mubareka S, Richards H, Gray M, Tipples GA.

J Clin Microbiol. 2007 Jan;45(1):231-3. Epub 2006 Nov 8.

15.

Genomic cartography of varicella-zoster virus: a complete genome-based analysis of strain variability with implications for attenuation and phenotypic differences.

Tyler SD, Peters GA, Grose C, Severini A, Gray MJ, Upton C, Tipples GA.

Virology. 2007 Mar 15;359(2):447-58. Epub 2006 Oct 25.

17.

Prevention of congenital rubella syndrome--what makes sense in 2006?

Robinson JL, Lee BE, Preiksaitis JK, Plitt S, Tipples GA.

Epidemiol Rev. 2006;28:81-7. Epub 2006 Jun 14. Review.

PMID:
16775038
18.
19.

Evaluation of rubella IgM enzyme immunoassays.

Tipples GA, Hamkar R, Mohktari-Azad T, Gray M, Ball J, Head C, Ratnam S.

J Clin Virol. 2004 Jul;30(3):233-8.

PMID:
15135741
20.

Measles elimination in Canada.

King A, Varughese P, De Serres G, Tipples GA, Waters J; Working Group on Measles Elimination.

J Infect Dis. 2004 May 1;189 Suppl 1:S236-42.

PMID:
15106117
21.

Genotyping of measles virus in Canada: 1979-2002.

Tipples GA, Gray M, Garbutt M, Rota PA; Canadian Measles Surveillance Program.

J Infect Dis. 2004 May 1;189 Suppl 1:S171-6.

PMID:
15106107
22.

Molecular epidemiology of measles virus in Kenya.

Mbugua FM, Okoth FA, Gray M, Kamau T, Kalu A, Eggers R, Borus P, Kombich J, Langat A, Maritim P, Lesiamon J, Tipples GA.

J Med Virol. 2003 Dec;71(4):599-604.

PMID:
14556275
23.
24.

Assessment of immunoglobulin M enzyme immunoassays for diagnosis of measles.

Tipples GA, Hamkar R, Mohktari-Azad T, Gray M, Parkyn G, Head C, Ratnam S.

J Clin Microbiol. 2003 Oct;41(10):4790-2.

25.

Structure of replicating intermediates of human herpesvirus type 6.

Severini A, Sevenhuysen C, Garbutt M, Tipples GA.

Virology. 2003 Sep 15;314(1):443-50.

26.

Mapping ganciclovir resistance in the human herpesvirus-6 U69 protein kinase.

Safronetz D, Petric M, Tellier R, Parvez B, Tipples GA.

J Med Virol. 2003 Nov;71(3):434-9.

PMID:
12966551
27.

Differentiation and quantitation of human herpesviruses 6A, 6B and 7 by real-time PCR.

Safronetz D, Humar A, Tipples GA.

J Virol Methods. 2003 Sep;112(1-2):99-105.

PMID:
12951217
28.

Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening.

Walters KA, Tipples GA, Allen MI, Condreay LD, Addison WR, Tyrrell L.

Antimicrob Agents Chemother. 2003 Jun;47(6):1936-42.

29.

The Genome sequence of the SARS-associated coronavirus.

Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YS, Khattra J, Asano JK, Barber SA, Chan SY, Cloutier A, Coughlin SM, Freeman D, Girn N, Griffith OL, Leach SR, Mayo M, McDonald H, Montgomery SB, Pandoh PK, Petrescu AS, Robertson AG, Schein JE, Siddiqui A, Smailus DE, Stott JM, Yang GS, Plummer F, Andonov A, Artsob H, Bastien N, Bernard K, Booth TF, Bowness D, Czub M, Drebot M, Fernando L, Flick R, Garbutt M, Gray M, Grolla A, Jones S, Feldmann H, Meyers A, Kabani A, Li Y, Normand S, Stroher U, Tipples GA, Tyler S, Vogrig R, Ward D, Watson B, Brunham RC, Krajden M, Petric M, Skowronski DM, Upton C, Roper RL.

Science. 2003 May 30;300(5624):1399-404. Epub 2003 May 1.

30.

New variant of varicella-zoster virus.

Tipples GA, Stephens GM, Sherlock C, Bowler M, Hoy B, Cook D, Grose C.

Emerg Infect Dis. 2002 Dec;8(12):1504-5.

31.

Structure-activity relationship of a new class of anti-hepatitis B virus agents.

Mehta A, Conyers B, Tyrrell DL, Walters KA, Tipples GA, Dwek RA, Block TM.

Antimicrob Agents Chemother. 2002 Dec;46(12):4004-8.

32.
33.

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group.

Allen MI, Deslauriers M, Andrews CW, Tipples GA, Walters KA, Tyrrell DL, Brown N, Condreay LD.

Hepatology. 1998 Jun;27(6):1670-7.

PMID:
9620341
34.

Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo.

Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrrell DL.

Hepatology. 1996 Sep;24(3):714-7.

PMID:
8781348

Supplemental Content

Loading ...
Support Center